| Characterization of the recognition and functional heterogeneity exhibited by cytokine‐induced killer cell subsets against acute myeloid leukaemia target cell YC Linn, SKJ Lau, BH Liu, LH Ng, HX Yong, KM Hui Immunology 126 (3), 423-435, 2009 | 179 | 2009 |
| SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes HW Jeong, W Cui, Y Yang, J Lu, J He, A Li, D Song, Y Guo, BH Liu, ... PloS one 6 (4), e18372, 2011 | 82 | 2011 |
| Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide BH Liu, C Jobichen, CSB Chia, THM Chan, JP Tang, TXY Chung, J Li, ... Proceedings of the National Academy of Sciences 115 (30), E7119-E7128, 2018 | 64 | 2018 |
| New high-throughput screening identifies compounds that reduce viability specifically in liver cancer cells that express high levels of SALL4 by inhibiting oxidative … JL Tan, F Li, JZ Yeo, KJ Yong, MA Bassal, GH Ng, MY Lee, CY Leong, ... Gastroenterology 157 (6), 1615-1629. e17, 2019 | 59 | 2019 |
| A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis A Li, Y Yang, C Gao, J Lu, HW Jeong, BH Liu, P Tang, X Yao, D Neuberg, ... The Journal of clinical investigation 123 (10), 4195-4207, 2013 | 56 | 2013 |
| Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis BH Liu, CHK Goh, L Ooi, KM Hui Oncogene 27 (29), 4128-4136, 2008 | 18 | 2008 |
| Styryl Quinazolinones as potential inducers of myeloid differentiation via Upregulation of C/EBPα R Sridhar, H Takei, R Syed, IS Kobayashi, LB Hui, A Kamal, DG Tenen, ... Molecules 23 (8), 1938, 2018 | 9 | 2018 |
| Spalt-like transcription factor 4 (SALL4) and uses thereof L Chai, T Dimitrov, DG Tenen, KJ Yong, BH Liu US Patent 9,365,851, 2016 | 5 | 2016 |
| Molecular glue and sall4 degrader VU Le Kim Anh, BH Liu, DG Tenen US Patent App. 18/293,684, 2024 | | 2024 |
| Targeting transcription factors through an IMiD independent zinc finger domain BH Liu, M Liu, S Radhakrishnan, CK Jaladanki, C Gao, JP Tang, ... bioRxiv, 2024.01. 03.574032, 2024 | | 2024 |
| Targeting the Oncofetal Transcription Factor Protein SALL4 in Cancer By a Non-IMiD Degrader KAL Vu, K Kumari, BH Liu, C Gao, F Li, JP Tang, D Maddalo, X Tian, ... Blood 142, 7144, 2023 | | 2023 |
| SALL4B, not targeted by IMiD, is important for SALL4-mediated tumorigenesis KA L. Vu, K Kumari, BH Liu, C Gao, F Li, JP Tang, D Maddalo, DS Auld, ... bioRxiv, 2023.07. 07.548071, 2023 | | 2023 |
| N-(2-aminophenyl)-prop-2-enamide derivatives, and uses thereof in the treatment of cancer S Radhakrishnan, DG Tenen, BH Liu, KAV Le, ML Go, L Chai, ... | | 2022 |
| Therapeutic spalt-like transcription factor 4 (SALL4) peptide BH Liu, DG Tenen, L Chai, CSB Chia, A Poulsen US Patent 10,793,601, 2020 | | 2020 |
| A high-throughput chemical genetic screen reveals SALL4-induced metabolic vulnerabilities in cancer JL Tan, F Li, JZ Yeo, KJ Yong, MA Bassal, GH Ng, MY Lee, CY Leong, ... Cancer Research 80 (16_Supplement), 1788-1788, 2020 | | 2020 |
| Identification of unique and common low abundance tumor-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis BH Liu, C Goh, LL Ooi, K Hui Clinical Cancer Research 13 (22_Supplement), A54-A54, 2007 | | 2007 |
| Therapeutic SALL4 Peptide CSBCAP Bee Hui Liu, Daniel Geoffrey Tenen, Li Chai SG Patent PCT/US2017/030,164, 0 | | |
| SALL4 and Uses thereof LC Boston MA), DGTS Todor Dimitrov (Boston MA), KJY Singapore), ... SG Patent US Patent 9,385,651 B, 0 | | |
